River Road Asset Management LLC Buys New Stake in InMode Ltd. (NASDAQ:INMD)

River Road Asset Management LLC purchased a new position in shares of InMode Ltd. (NASDAQ:INMD - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 513,278 shares of the healthcare company's stock, valued at approximately $8,572,000. River Road Asset Management LLC owned about 0.61% of InMode as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of INMD. PNC Financial Services Group Inc. increased its stake in InMode by 17.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 21,208 shares of the healthcare company's stock valued at $354,000 after acquiring an additional 3,193 shares during the period. Marco Investment Management LLC increased its stake in shares of InMode by 5.2% in the fourth quarter. Marco Investment Management LLC now owns 37,835 shares of the healthcare company's stock valued at $632,000 after buying an additional 1,860 shares in the last quarter. Ashton Thomas Private Wealth LLC bought a new position in shares of InMode in the fourth quarter valued at about $282,000. Raymond James Financial Inc. acquired a new position in InMode during the 4th quarter worth about $1,332,000. Finally, Seizert Capital Partners LLC grew its holdings in InMode by 105.2% during the 4th quarter. Seizert Capital Partners LLC now owns 250,627 shares of the healthcare company's stock worth $4,185,000 after acquiring an additional 128,483 shares during the last quarter. 68.04% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

INMD has been the subject of several research analyst reports. Barclays boosted their price objective on shares of InMode from $26.00 to $29.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 5th. Needham & Company LLC restated a "hold" rating on shares of InMode in a research report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, InMode presently has an average rating of "Hold" and an average target price of $22.25.

Remove Ads

InMode Stock Down 2.8 %

NASDAQ:INMD opened at $18.81 on Wednesday. InMode Ltd. has a 12-month low of $14.87 and a 12-month high of $22.00. The stock's fifty day simple moving average is $17.84 and its 200-day simple moving average is $17.57. The firm has a market capitalization of $1.31 billion, a P/E ratio of 8.00 and a beta of 2.07.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.